glp 1 through ro Patients with diabetes who remained on GLP-1 drugs had lower cardiovascular risk Association of GLP-1 inhibitors with

PMID 20027008

Mood and appetite are closely related (think of stressful eating or eating when we are sad, comfort food), and a benefit of GLP1-Ra is that they help control appetite and satiety, which allows patients to make better meal choices and become healthier

Food and Drug Administration have banned the sale of compounded weight loss drugs including Ozempic, Mounjaro, Wegovy and Zepbound

Safety Management Considerations: Gastrointestinal side effects predominate, but are generally manageable via dose titration

A Rich R&D Pipeline : As companies continue to develop differentiated therapies with added advantages, the eligible patient population will keep growing